The elevated expression of ALCAM-Iso2 observed in the tumor tissue from bladder cancer patients (Fig. 7c,d) gives further support to the hypothesis that alternative splicing of ALCAM contributes to the progression of cancer. The gene discussed is ALCAM; the disease is urinary bladder cancer.